NCT00800761View on ClinicalTrials.gov

Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2001

Primary Completion Date

June 30, 2006

Study Completion Date

June 30, 2006

Conditions
Iron OverloadCardiomyopathy
Interventions
DRUG

Deferoxamine and Deferiprone

comparison of two arms: the first one treated with deferoxamine subcutaneous vials,40 mg/kg,12 hours/die plus deferiprone tablets 75 mg/kg three times/die versus the second one treated with deferoxamine subcutaneous vials,40 mg/kg,12 hours/die

DRUG

Deferoxamine

deferoxamine vials,40 mg/kg,12 hours/die

Trial Locations (1)

09121

Adult Talassemic Center, Ospedale Microcitemico, Cagliari

All Listed Sponsors
collaborator

Azienda Sanitaria Locale di Cagliari

OTHER

lead

Ospedale Microcitemico

OTHER

NCT00800761 - Intensive Combined Chelation Therapy for Iron-Induced Cardiac Disease in Patients With Thalassemia Major | Biotech Hunter | Biotech Hunter